Orchid Pharma Statistics

Total Valuation

Orchid Pharma has a market cap or net worth of INR 41.01 billion. The enterprise value is 40.22 billion.

Market Cap	41.01B
Enterprise Value	40.22B

Important Dates

The next estimated earnings date is Friday, May 30, 2025.

Earnings Date	May 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Orchid Pharma has 50.72 million shares outstanding. The number of shares has increased by 10.51% in one year.

Current Share Class	n/a
Shares Outstanding	50.72M
Shares Change (YoY)	+10.51%
Shares Change (QoQ)	-0.10%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	26.14%
Float	15.19M

Valuation Ratios

The trailing PE ratio is 36.98 and the forward PE ratio is 30.84.

PE Ratio	36.98
Forward PE	30.84
PS Ratio	4.55
PB Ratio	3.35
P/TBV Ratio	3.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	36.27
EV / Sales	4.46
EV / EBITDA	40.16
EV / EBIT	47.15
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.13
Debt / EBITDA	1.65
Debt / FCF	n/a
Interest Coverage	6.04

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	4.02%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	10.35M
Profits Per Employee	1.27M
Employee Count	871
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.09% in the last 52 weeks. The beta is 1.96, so Orchid Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.96
52-Week Price Change	-25.09%
50-Day Moving Average	865.68
200-Day Moving Average	1,329.21
Relative Strength Index (RSI)	48.44
Average Volume (20 Days)	102,327

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orchid Pharma had revenue of INR 9.02 billion and earned 1.11 billion in profits. Earnings per share was 21.87.

Revenue	9.02B
Gross Profit	3.48B
Operating Income	851.15M
Pretax Income	1.08B
Net Income	1.11B
EBITDA	996.32M
EBIT	851.15M
Earnings Per Share (EPS)	21.87

Full Income Statement

Balance Sheet

The company has 2.44 billion in cash and 1.65 billion in debt, giving a net cash position of 789.49 million or 15.57 per share.

Cash & Cash Equivalents	2.44B
Total Debt	1.65B
Net Cash	789.49M
Net Cash Per Share	15.57
Equity (Book Value)	12.24B
Book Value Per Share	241.38
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 38.66%, with operating and profit margins of 9.44% and 12.30%.

Gross Margin	38.66%
Operating Margin	9.44%
Pretax Margin	11.94%
Profit Margin	12.30%
EBITDA Margin	11.05%
EBIT Margin	9.44%
FCF Margin	n/a

Dividends & Yields

Orchid Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.51%
Shareholder Yield	-10.51%
Earnings Yield	2.70%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a